Trevena Inc.

(TRVN) Trade

By |

Profile

Trevena Inc is a clinical stage biopharmaceutical company. It discovers, develops and commercialize therapeutics that use a novel approach to target G protein coupled receptors.

Contact Information

Website: www.trevenainc.com
Email: IR@trevenainc.com
Main Phone: +1 610 354-8840
Address: 955 Chesterbrook Boulevard
Address 2: Suite 200
State: PA
City / Town: Chesterbrook
Country: USA
Postal Code: 19087

Issuer Information

Exchange: NGS
CEO: Maxine Gowen
Employees: 51
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 1.63 $ -0.045 (-2.69%)
Last Price 1.63 Change $ -0.045 Change % -2.69 Tick N/A
Bid 1.62 Bid Size 17,600.00 Ask 1.63 Ask Size 6,100.00
Open 1.67 High 1.68 Low 1.62 Prev Close 1.67
Last Trade Volume 908,501 52 Wk Hi 3.10 52 Wk Low 1.34
Market Cap 110.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 67,968,713.00 EPS (TTM) -0.99 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 1
Number of Buys 0 0
Number of Sells 1 1
Net Activity -5000 -5000
Last 10 Buys Shares
Carrie L. Bourdow 1,000
Maxine Gowen 1,000
Yacoub Habib 1,000
Maxine Gowen 1,000
Maxine Gowen 1,000
Maxine Gowen 1,000
Roberto Cuca 1,000
John M. Limongelli 1,000
Last 10 Sell Shares
Yacoub Habib 1,000
Michael W. Lark 1,000
David Soergel 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 2.5 2.5 2.5 2.5
Mean Target Price Estimate 6.92 6.92 6.92 6.92
Standard Deviation 2.91 2.91 2.91 2.91
Date of Most Recent Estimate 05/23/18 05/23/18 05/23/18 05/23/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.4 1.5 1.5